Technical Analysis for HOTH - Hoth Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| 20 DMA Resistance | Bearish | 1.68% | |
| Bollinger Band Squeeze | Range Contraction | 1.68% | |
| Gapped Up | Strength | 1.68% | |
| 20 DMA Resistance | Bearish | 3.42% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 3.42% | |
| Bollinger Band Squeeze | Range Contraction | 3.42% | |
| BB Squeeze Started | Range Contraction | 3.42% |
| Alert | Time |
|---|---|
| 20 DMA Support | about 19 hours ago |
| 10 DMA Support | about 19 hours ago |
| Gap Up Closed | about 20 hours ago |
| 20 DMA Resistance | about 20 hours ago |
| 10 DMA Resistance | about 20 hours ago |
Get a Trading Sidekick!
- Earnings date: 05/15/2024
Hoth Therapeutics, Inc. Description
Hoth Therapeutics Inc., a Nevada corporation, is a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema. Hoth has exclusive worldwide rights to the BioLexa Platform. Hoth intends to use the BioLexa Platform to develop two different topical cream products: (i) a product to treat eczema and (ii) a product that reduces post-procedure infections, accelerates healing and improves clinical outcomes for patients undergoing aesthetic dermatology procedures. Hoth’s initial focus will be on the development of the BioLexa Platform for the treatment of eczema. Eczema is a disease that results in inflammation of the skin and is characterized by rash, red skin, and itchiness. Eczema is also referred to as atopic dermatitis.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Disease Immunology Inflammation Dermatology Atopic Dermatitis Healing Dermatitis Type I Hypersensitivity Atopy Eczema Itchiness Sodium Hypochlorite Washes
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.3 |
| 52 Week Low | 0.99 |
| Average Volume | 541,981 |
| 200-Day Moving Average | 1.52 |
| 50-Day Moving Average | 1.29 |
| 20-Day Moving Average | 1.20 |
| 10-Day Moving Average | 1.19 |
| Average True Range | 0.08 |
| RSI (14) | 47.37 |
| ADX | 23.27 |
| +DI | 9.08 |
| -DI | 14.02 |
| Chandelier Exit (Long, 3 ATRs) | 1.14 |
| Chandelier Exit (Short, 3 ATRs) | 1.35 |
| Upper Bollinger Bands | 1.25 |
| Lower Bollinger Band | 1.14 |
| Percent B (%b) | 0.61 |
| BandWidth | 9.10 |
| MACD Line | -0.03 |
| MACD Signal Line | -0.04 |
| MACD Histogram | 0.0063 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.30 | ||||
| Resistance 3 (R3) | 1.30 | 1.26 | 1.28 | ||
| Resistance 2 (R2) | 1.26 | 1.24 | 1.26 | 1.28 | |
| Resistance 1 (R1) | 1.24 | 1.23 | 1.22 | 1.24 | 1.27 |
| Pivot Point | 1.20 | 1.20 | 1.19 | 1.20 | 1.20 |
| Support 1 (S1) | 1.18 | 1.18 | 1.16 | 1.18 | 1.15 |
| Support 2 (S2) | 1.14 | 1.17 | 1.15 | 1.14 | |
| Support 3 (S3) | 1.12 | 1.14 | 1.14 | ||
| Support 4 (S4) | 1.12 |
